RCKT vs TNYA
RCKT: Rocket Pharmaceuticals is a clinical-stage biotechnology company developing transformative gene therapies for rare, high-unmet-need genetic disorders. TNYA: Tenaya Therapeutics is a clinical-stage biopharmaceutical company leveraging gene therapy and small molecule platforms to develop curative, precision-medicine treatments for genetically defined heart diseases.
Side-by-side fundamentals
| Metric | RCKT | TNYA | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $3.30 | $0.79 | |
| Market cap as of 2026-07-23 | $368M | $171M | |
| ROE as of 2026-07-23 | -70.8% | -80.6% | RCKT higher |
| ROA as of 2026-07-23 | -59.6% | -65.2% | RCKT higher |
| Debt / equity as of 2026-07-23 | 0.09 | 0.00 | TNYA lower |
| Beta as of 2026-07-23 | 0.46 | 2.85 | |
| 1-year return as of 2026-07-22 close | -2.1% | -3.8% | RCKT higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.